ArticleTropical animal health and production2026
Dose-response effects of Tenebrio molitor oil dietary supplementation on production performance, egg quality, and economic outcomes in Japanese quail layers under tropical conditions.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Feed cost volatility associated with conventional lipid sources such as primarily soybean oil, palm oil, and animal fats; poses a persistent challenge to economically viable poultry production in tropical and resource-constrained regions. Mealworm oil (MWO), derived from Tenebrio molitor larvae, offers a nutritionally relevant lipid supplement with a favourable unsaturated fatty acid profile; controlled evidence for its supplementation in laying quail systems, and particularly formal economic evaluation, remain limited. This study evaluated dose-response effects of graded MWO supplementation (0%, 0.5%, 1.0%, 1.5%) on egg production performance, egg quality, reproductive organ morphology, and economic outcomes in Japanese quail layers (Coturnix japonica). A total of 200 eleven-week-old females were allocated to four dietary treatments (50 birds per treatment; five replicates of ten birds each) in a completely randomised design; in T1-T3, corn starch was replaced isoenergetically by MWO at 0.5%, 1.0%, and 1.5%, respectively. Production data were collected over four weeks (weeks 12-15 of age). MWO supplementation produced dose-dependent improvements in egg production percentage, egg mass, and feed conversion ratio (FCR) across all experimental weeks; at week 15, T3 recorded an FCR of 2.57 ± 0.10 versus 4.49 ± 0.20 in T0 (P < 0.0001) and an egg production percentage of 74.24%. Albumen weight and Haugh units were significantly higher in T3 at all measurement weeks (P < 0.05), while yolk cholesterol declined progressively with increasing MWO inclusion; however, the absolute magnitude of this reduction was modest (approximately 5-9 mg/100 g). Eggshell traits were unaffected. Relative weights of the oviduct, ovary, and F-1 follicle were significantly greater in T3 at terminal assessment (week 15). A formal partial-budget analysis under local market conditions (Peshawar, Pakistan) indicated that the FCR improvement at 1.5% MWO reduced feed cost per dozen eggs from 80.98 ± 0.80 to 55.43 ± 0.76 PKR and generated the highest gross margin (ΔΠ = +727.3 PKR per replicate versus T0) despite the higher unit cost of MWO relative to corn starch. These results indicate that low-level MWO dietary supplementation has the potential to enhance quail layer performance and economic returns under similar conditions to those examined in this study. However, further validation at a commercial scale, along with re-parameterization across diverse tropical production environments, is necessary before making broader claims regarding its applicability.
Indexed as
Identifiers
42360626What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.